75 related articles for article (PubMed ID: 959671)
1. Regional brain catecholamine levels after intraventricular 6-hydroxydopamine in the neonatal rat.
Pappas BA; Saari M; Peters AV
Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):751-4. PubMed ID: 959671
[No Abstract] [Full Text] [Related]
2. Tyrosine hydroxylase activity in brain regions after intraventricular 6-hydroxydopamine in the neonatal rat.
Peters DA; Pappas BA; Taub H; Saari M
Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):161-4. PubMed ID: 28554
[TBL] [Abstract][Full Text] [Related]
3. Effects of intraventricular and intra-aquaductal 6-hydroxydopamine on monoamine containing neurons of the fowl paleostriatum, diencephalon and mesencephalon.
Gargiulo G; Nisticò G; Rotiroti D; De Girolamo G
Basic Appl Histochem; 1979; 23(3):211-9. PubMed ID: 533517
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
Sorenson CA; Vayer JS; Goldberg CS
Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
[No Abstract] [Full Text] [Related]
5. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
Peters DA; Pappas BA; Taub H; Saari M
Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
[No Abstract] [Full Text] [Related]
6. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
Peterson DW; Sparber SB
J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
[No Abstract] [Full Text] [Related]
7. Effects of intraventricular 6-hydroxydopamine on cerebrovascular CO2 reactivity in anesthetized rats.
Edvinsson L; Hardebo JE; MacKenzie ET
Acta Physiol Scand; 1977 Sep; 101(1):122-5. PubMed ID: 906856
[TBL] [Abstract][Full Text] [Related]
8. Effect of nerve degeneration by 6-hydroxydopamine on catecholamine-stimulated adenosine 3',5'-monophosphate formation in rat cerebral cortex.
Kalisker A; Rutledge CO; Perkins JP
Mol Pharmacol; 1973 Sep; 9(5):619-29. PubMed ID: 4363016
[No Abstract] [Full Text] [Related]
9. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
Suenaga N; Yamada K; Fukuda T
Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
[No Abstract] [Full Text] [Related]
10. The production of piperidine from pipecolic acid in the rat brain.
Kasé Y; Okano Y; Miyata T; Kataoka M; Yonehara N
Life Sci; 1974 Feb; 14(4):785-91. PubMed ID: 4823631
[No Abstract] [Full Text] [Related]
11. Effect of 6-hydroxydopamine on the level of the catecholamines in the brain of developing rats.
Brus R
Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):71-6. PubMed ID: 4717390
[No Abstract] [Full Text] [Related]
12. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
Fobes JL; Olds ME
Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
[TBL] [Abstract][Full Text] [Related]
13. Catecholamines in rat brain following postnatal undernutrition and nutritional rehabilitation.
Wiggins RC; Fuller GN; Seifert WE; Butler IJ; Gottesfeld Z
J Neurosci Res; 1982; 8(4):651-6. PubMed ID: 7161844
[TBL] [Abstract][Full Text] [Related]
14. [Right/left discrimination learning in rat pups neonatally treated with 6-hydroxydopamine].
Takasuna M; Iwasaki T
Yakubutsu Seishin Kodo; 1990 Jun; 10(2):315-21. PubMed ID: 2123587
[TBL] [Abstract][Full Text] [Related]
15. Selective depletion of dopamine following O-methylation of 6-hydroxydopamine.
Ho BT; Meyer AL; Taylor D
Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):47-56. PubMed ID: 4734016
[No Abstract] [Full Text] [Related]
16. Proceedings: Failure to induce experimental hypertension in rats after intraventricular injection of 6-hydroxydopamine.
Finch L; Haeusler G; Thoenen H
Br J Pharmacol; 1972 Feb; 44(2):356P-357P. PubMed ID: 4148920
[No Abstract] [Full Text] [Related]
17. Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
Lytle LD; Shoemaker WJ; Cottman K; Wurtman RJ
J Pharmacol Exp Ther; 1972 Oct; 183(1):56-64. PubMed ID: 5080034
[No Abstract] [Full Text] [Related]
18. Comparison of the effects of intracranial injections of 6-OHDA and guanethidine on consummatory behavior and monoamine depletion.
Singer G; Armstrong S; Evans B; Burnstock G
Pharmacol Biochem Behav; 1975; 3(1 Suppl):91-106. PubMed ID: 1226403
[TBL] [Abstract][Full Text] [Related]
19. [Effect of neonatal 6-hydroxydopamine administration on the catecholaminergic structures of the hypothalamus and on the behavior of rats of various ages].
Konstantinova MS; Semenova TP; Grishchenko NI; Gromova EA; Polenov AL
Ontogenez; 1989; 20(3):332-6. PubMed ID: 2549482
[TBL] [Abstract][Full Text] [Related]
20. Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments.
Cooper BR; Cott JM; Breese GR
Psychopharmacologia; 1974 Jul; 37(3):235-48. PubMed ID: 4851731
[No Abstract] [Full Text] [Related]
[Next] [New Search]
